Technical Analysis for BSX - Boston Scientific Corporation

Grade Last Price % Change Price Change
A 67.24 1.52% 1.01
BSX closed up 1.52 percent on Monday, March 18, 2024, on 86 percent of normal volume.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Fell Below 20 DMA Bearish 1.52%
1,2,3 Pullback Bullish Bullish Swing Setup 1.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.52%
Bollinger Band Squeeze Range Contraction 1.52%
Gapped Down Weakness 1.52%
Crossed Above 20 DMA Bullish 0.57%
1,2,3 Pullback Bullish Bullish Swing Setup 0.57%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.57%

   Recent Intraday Alerts

Alert Time
Up 1 ATR about 16 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Rose Above 10 DMA about 18 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 18 hours ago
1,2,3, Pullback Entry about 18 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Boston Scientific Corporation Description

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Clinical Medicine Disease Medical Technology Catheter Technology Products Heart Failure Chronic Pain Interventional Radiology Ultrasound Cardiology Neuromodulation Prosthetics Ablation Cardiac Electrophysiology Artery Endoscopy Protection Devices Medical Technologies Artery Disease Benign Prostatic Hyperplasia Biomedical Engineering Hyperplasia Peripheral Vascular Disease Coronary Artery Disease Interventional Cardiology Angiography Angioplasty Balloon Catheter Percutaneous Neuromodulation Products Artificial Cardiac Pacemaker Embolic Protection Device Endoscopy Products Lithotripsy Rhythm Disorders Synchronization

Is BSX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 68.065
52 Week Low 47.515
Average Volume 6,807,888
200-Day Moving Average 55.77
50-Day Moving Average 64.12
20-Day Moving Average 66.82
10-Day Moving Average 66.99
Average True Range 1.04
RSI (14) 57.08
ADX 40.14
+DI 18.91
-DI 13.86
Chandelier Exit (Long, 3 ATRs) 64.94
Chandelier Exit (Short, 3 ATRs) 68.46
Upper Bollinger Bands 67.99
Lower Bollinger Band 65.66
Percent B (%b) 0.68
BandWidth 3.48
MACD Line 0.75
MACD Signal Line 1.02
MACD Histogram -0.2652
Fundamentals Value
Market Cap 98.51 Billion
Num Shares 1.46 Billion
EPS 1.07
Price-to-Earnings (P/E) Ratio 62.84
Price-to-Sales 6.74
Price-to-Book 5.08
PEG Ratio 2.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 69.14
Resistance 3 (R3) 68.99 68.21 68.82
Resistance 2 (R2) 68.21 67.72 68.28 68.72
Resistance 1 (R1) 67.72 67.42 67.97 67.87 68.61
Pivot Point 66.94 66.94 67.06 67.02 66.94
Support 1 (S1) 66.46 66.46 66.70 66.61 65.87
Support 2 (S2) 65.68 66.16 65.75 65.76
Support 3 (S3) 65.19 65.68 65.66
Support 4 (S4) 65.34